Is BPC 157 Banned? Oral vs. Injectable Forms Explained FDA Sends Warning Letters to Multiple Companies for Illegally Selling Adulterated Dietary Supplements FDA FDA to weigh easing limits on unproven peptides Peptide Therapy in Boise Specialized Treatment for First Responders Blueline Wellness The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures